Market revenue in 2024 | USD 7,316.3 million |
Market revenue in 2030 | USD 9,443.3 million |
Growth rate | 4.3% (CAGR from 2024 to 2030) |
Largest segment | Contraceptive devices |
Fastest growing segment | Contraceptive Devices |
Historical data covered | 2018 - 2023 |
Base year for estimation | 2024 |
Forecast period covered | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Contraceptive Drugs, Contraceptive Devices |
Key market players worldwide | Bayer AG, Cupid, Helm AG, Church & Dwight Co Inc, Organon & Co Ordinary Shares, Pfizer Inc, Viatris Inc, AbbVie Inc, Afaxys, Veru Inc, Agile Therapeutics Inc, Janssen Pharmaceuticals, China Resources Pharmaceutical Group Ltd Registered Shs Unitary 144A/Reg S, Crinetics Pharmaceuticals Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to contraceptive market will help companies and investors design strategic landscapes.
Contraceptive devices was the largest segment with a revenue share of 71.77% in 2024. Horizon Databook has segmented the Europe contraceptive market based on contraceptive drugs, contraceptive devices covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe contraceptive market , including forecasts for subscribers. This continent databook contains high-level insights into Europe contraceptive market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account